Predictive and Prognostic Value of CA 19-9 in Resected Pancreatic Adenocarcinoma
- 1 November 2009
- journal article
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 13 (11) , 2050-2058
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- The Use of Adjusted Preoperative CA 19-9 to Predict the Recurrence of Resectable Pancreatic CancerJournal of Surgical Research, 2007
- Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancerSurgery, 2007
- 1423 Pancreaticoduodenectomies for Pancreatic Cancer: A Single-Institution ExperienceJournal of Gastrointestinal Surgery, 2006
- Borderline Resectable Pancreatic Cancer: Definitions, Management, and Role of Preoperative TherapyAnnals of Surgical Oncology, 2006
- Perioperative CA19-9 Levels Can Predict Stage and Survival in Patients With Resectable Pancreatic AdenocarcinomaJournal of Clinical Oncology, 2006
- Elevated tumour marker CA19-9: clinical interpretation and influence of obstructive jaundiceEuropean Journal of Surgical Oncology, 2000
- An Argument Against Routine Percutaneous Biopsy, ERCP, or Biliary Stent Placement in Patients with Clinically Resectable Periampullary MassesPancreas, 1995
- Prognostic Values of Preoperative and Postoperative CEA and CA19.9 Levels in Pancreatic CancerPancreas, 1994
- Diagnosis of Pancreatic Cancer and Prediction of Unresectability Using the Tumor-Associated Antigen CA19-9Pancreas, 1994
- Prognostic Value of Serum CA 19–9 Levels in Pancreatic AdenocarcinomaAnnals of Surgery, 1992